Mozavaptan Hydrochloride

盐酸莫扎伐普坦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMozavaptan Hydrochloride
Drug Alias NameMozavaptanum莫扎伐坦莫扎伐普坦莫扎伐普坦盐酸盐Physuline +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V2 receptor antagonists
TargetsVasopressin V2 receptor
Therapy Area/IndicationsHyponatremia
Global Approved IndicationsHyponatremia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2006/07/26
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Holdings Co Ltd
Inactive CompaniesN/A
Active IndicationsHyponatremia
Inactive IndicationsN/A

Other Information

ATC CodeC03XA
Related LinksWikipediaKEGG